Your Health. Your Family. Your Choice.
Life Threatening? No
Write-up: TMJ syndrome; This is a spontaneous report from a contactable consumer. This is a report received from the regulatory Authority report number GB-MHRA-WEBCOVID-202109131539146870-PGX42, Safety Report Unique Identifier GB-MHRA-ADR 25932518. A 25-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 10Sep2021, as a single dose for COVID-19 immunisation. Medical history included depression. The patient has not had symptoms associated with COVID-19 and was not enrolled in clinical trial. The patient was not breastfeeding at the time of this report. Concomitant medications included fluoxetine (MANUFACTURER UNKNOWN) for depression from an unknown date and unknown if ongoing. On 12Sep2021, 2 days after the vaccination, the patient experienced temporomandibular joint (TMJ) syndrome, reported as serious for being medically significant. On an unknown date, the patient underwent COVID-19 virus test and the result was negative. The patient has not tested positive for COVID-19 since having the vaccine. The clinical outcome of the event TMJ syndrome was resolving at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166